BCUR Stock Overview
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Erika B-Cure Laser Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪0.38 |
| 52 Week High | ₪0.45 |
| 52 Week Low | ₪0.15 |
| Beta | 1.56 |
| 1 Month Change | -9.76% |
| 3 Month Change | 35.36% |
| 1 Year Change | 133.95% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -93.92% |
Recent News & Updates
Shareholder Returns
| BCUR | IL Medical Equipment | IL Market | |
|---|---|---|---|
| 7D | -4.8% | -1.5% | 0.3% |
| 1Y | 134.0% | 4.8% | 11.6% |
Return vs Industry: BCUR exceeded the IL Medical Equipment industry which returned 4% over the past year.
Return vs Market: BCUR exceeded the IL Market which returned 9.8% over the past year.
Price Volatility
| BCUR volatility | |
|---|---|
| BCUR Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.4% |
| 10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: BCUR's share price has been volatile over the past 3 months.
Volatility Over Time: BCUR's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 56 | Moti Navon | bcurelaser.com |
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic problems, diabetic wounds, and difficulties in healing and mucositis. The company also provides B-Cure Laser Sport, a home device for treating injuries and sports pain, orthopedics, and others; and B-Cure Laser Sport Pro, a professional device for treating sports injuries, and pain relief in areas of the body and muscles, as well as infections, including Achilles tendonitis.
Erika B-Cure Laser Ltd Fundamentals Summary
| BCUR fundamental statistics | |
|---|---|
| Market cap | ₪39.48m |
| Earnings (TTM) | -₪34.78m |
| Revenue (TTM) | ₪37.05m |
1.1x
P/S Ratio-1.1x
P/E RatioIs BCUR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BCUR income statement (TTM) | |
|---|---|
| Revenue | ₪37.05m |
| Cost of Revenue | ₪6.42m |
| Gross Profit | ₪30.63m |
| Other Expenses | ₪65.41m |
| Earnings | -₪34.78m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.33 |
| Gross Margin | 82.68% |
| Net Profit Margin | -93.90% |
| Debt/Equity Ratio | 4.9% |
How did BCUR perform over the long term?
See historical performance and comparison